Novocure Ltd (NVCR)

[TiltMyBrain]

And the insiders continue to sell. They hate the shareholders

[whosleftholdindabag]

One more purchase 27.5k shares of $NVCR to finish off the year! GLTA

[Garyedward71]

Here comes the sub 10s.

[Garyedward71]

Here comes the sub 10s.

[TiltMyBrain]

This is a painful death for the shareholders

[jdheart101]

I told ya 12 coming months ago , only hope is sell come to nwbo

[dstock07734]

Optune has a dire future. The tail-spin mode of the sp will continue and it is going to get worse in the next few weeks. You are still advocating it. No offense the two boards you are moderating have pretty bad record in terms of sp.

800 GBM patients have received DCVax-L and the increase over the last three months is 200. Those patients have to pay everything out of their own pockets. If they were not convinced by provable records on the efficacy of DCVax-L, would they try DCVax-L?

Have you read my DD which clearly indicates that DCVax-L is on the radar of the Moonshot program? There is no chance Optune is going to win. Do the right thing and tell the investors the truth.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172924113

[KIPK]

Present away - This wearable thing is very costly hope as it Lacks effectiveness IMO.... And now everyone is very aware of that IMO...
That's why SP has been dropping continuously from a high of about $82 in early June to $16 last Friday!!
The cat is out of the hat...

[jondoeuk]

Also at SITC

Abstract Number 581: Final analysis of 2-THE-TOP: A phase 2 study of TTFields (Optune) plus pembrolizumab plus maintenance temozolomide (TMZ) in patients with newly diagnosed glioblastoma.

Abstract Number 607: TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in the pivotal LUNAR study.

Abstract Number 1080: Tumor Treating Fields (TTFields) application induces a pro-inflammatory phenotype in macrophages.

[jondoeuk]

Upcoming https://finance.yahoo.com/news/novocure-announces-presence-american-society-210000443.html

[dstock07734]

I thought before only the poor need help. Now it seems like the rich need help too. I mean if that whoisabagholder fella is really rich.

[KIPK]

Wonder Wko is Holding Da Bag???

[jdheart101]

Bahahaha, a lot of nothing

[KIPK]

Time to Add Another Lot?????

[jdheart101]

Told ya a while back 12 coming , soon nwbo will meet nvcr around 12 nvcr will go single digits and nwbo 20s ,

[dstock07734]

It is really the time to reconsider your investment in NVCR. It is so simple: Download the paper and consult several best experts on immunotherapy to seek their opinions.

Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients

https://doi.org/10.21203/rs.3.rs-3287211/v1

[KIPK]

Step by step cookie is crumbling!!

[KIPK]

This person, whosleftholdindabag, is most likely a NWBO basher and a Pretend NVCR Investor IMO..

His posting history shows only 18 Posts on NVCR MB, WHILE having posted 820 on NWBO MB...

And that history support why he might be connected to EX..

[dstock07734]

It seems like he is not playing the game with his own money. As he repeatedly claimed, all the proceeds from the investment will go to charity. What will happen if there are no proceeds?

Can any longs in NWBO give credit to anyone who liked EX's posts? Absolutely not. In fact, he and EX are on the same league.

[jdheart101]

Just a bigger bag holder lol

[whosleftholdindabag]

Added another 12.5k shares of $NVCR today! GLTA

[KIPK]

Some got $230. $100. $50, $40, $30, $20, etc.. That trend as been post Trial data reporting!!

[AKATITUS]

Some got 18
19 teens

[KIPK]

LOL - Published, 'OS 13,2 months vs OS 9.9 months Yes. But is it worth the Trouble, Cost, & Hope??
"Overall survival was significantly longer with TTFields therapy and standard therapy than with standard therapy alone (median 13·2 months [95% CI 10·3–15·5] vs 9·9 months [8·1–11·5]

[jondoeuk]

It has now been published https://www.sciencedirect.com/science/article/abs/pii/S1470204523003443

[KIPK]

Who is Holding The Bag? Unsubstantiated Claim of $1.5M additional Investment here?? What a Gambler.. LOL

[AKATITUS]

Nice

[whosleftholdindabag]

Added another 75k shares of $NVCR this morning! GLTA

[dstock07734]

How could you post it so late? Did I mention months ago that it smells fishy since each member of NVCR C-Suite started selling after May 28 2018 on which the first results of DCVax-L p3 trial results were published? Do you remember what you said back then? You should resign from this board as a moderator.

[jondoeuk]

INNOVATE-3 fails. According to its final data analysis, the patients treated with TTFields plus paclitaxel had a mOS of 12.2 months compared to 11.9 months mOS in the paclitaxel-only arm https://www.businesswire.com/news/home/20230828160039/en/Novocure-Provides-Update-on-Phase-3-ENGOT-ov50-GOG-3029-INNOVATE-3-Trial-Evaluating-Tumor-Treating-Fields-Therapy-in-Platinum-resistant-Ovarian-Cancer/

[KIPK]

You should have listened, YES - Bottomed & Going to Neverland IMO. Air Out. Hype/Pump, Finished!!

[TiltMyBrain]

This company is done

[KIPK]

Busted - An NVCR Cancer Charity Investor. Who Hates Other Cancer Therapy Companies, Who Is Admittedly a Gambler...

What a complete package of Disappointment..

[whosleftholdindabag]

$NVCR has bottomed and headed up!

Just arrived in Las Vegas, and excited to spend the next week playing in my favorite poker room! Have a great weekend everyone! GLTA

[dstock07734]

If any one wants to bail, here is the best option.

[dstock07734]

https://www.oncovir.com/about
Andres Salazar owns a family business which has the patent of poly-iclc, an essential ingredient for maximizing the efficacy of DCVax-L.

Here is the ongoing clinical trial which has Oncovir has one of the collaborators along with Merck.
https://classic.clinicaltrials.gov/ct2/show/NCT04201873?cond=atl-dc&draw=2&rank=1

Check the newly hired employees of Oncovir. They are high-caliber professionals and they don't join a company which has no future. Keep in mind that Oncovir was involved in over 70 clinical trials and none of them were successful. Its old patent of poly-iclc expired in July. But he filed for new patents already. Would you file a new patent and hire new employees if your product in the past 20 years didn't deliver not a single success?

[KIPK]

dstock07734.
You had this statement in one of your posts on NWBO board...

"All we need to know is if Andres Salazar is all-in poly-iclc, if he is, we just need to plan all-in too. If we cannot all in, at least, we can double, triple, or quadruple our current position. It is that simple!"

What do you mean by that & who is Andres Salazar??

Thanks

[KIPK]

IMO Dude is not a Charity Investor for Cancer, OTHERWISE he would invest unbiasedly to all potential new therapies...
This dude is Pumping NVCR & Bashing NWBO!! A Charitable human would never ever be So Selectively Revengeful!!

Dude hiding behind a great cause for whatever reason IMO...

[dstock07734]

He probably thinks thermo shorts his beloved NVCR. He should first question the integrity of the whole NVCR management team.

[KIPK]

whosleftholdindabag - Dude, show some respect for the world "Charity" - Your Childish posts on NWBO Docent HELP NVCR suddenly succeed.

Take a look at facts that after every trial reporting NVCR SP has dropped significanly, from a high of over $230 to where it is today....

In response to that negative development, Even The CEO and many insiders have dropped their DaBAG on retails like you....

You should ask for forgiveness!!

[KIPK]

A shameful Post on NWBO MB by the So-Called Charity Investor?? Don't Trust this thing & If there is a POS. that is NVCR imo.. SMH

"In other words, thermo NEEDS you to flip back around to help pump this POS. He and the other "friendly" investors continue to dump warrants/preferred conversions, common and cover shorts! IMHO

[dstock07734]

You want to know why. Here is the reason. Each member of C-suite has been dumping their position like crazy. Which patient in sane category would wear this armor thingy for minimum 18 hours a day if there is an excellent option that three shots will completely reprogram the immune system and trigger massive T-cells (CD4 & CD8) attack on tumor cells?

[rick172]

Why doesn't anyone post on NVCR board?

[dstock07734]

There is a disruptive breakthrough that can potentially cure all solid tumors. It is right in front of you and you choose to ignore it. But sooner or later you will see it and by then you probably have no contributions and gains going to Charity.

[KIPK]

Post Below is By the Charity Talker, who Keeps Bashing NWBO???..

" I want the World to be a better place and want to live to see breakthroughs in the treatment of ALL cancer, we aren't there yet but I hope we are close"

SMH... You blow your Cover Charity Investor... LOL

[KIPK]

The so-called "FOR CHARITY INVESTORS" find it necessary to go & BASH NWBO.. A Cancer Cure Company

Humm.. What a hypocrite!!

[whosleftholdindabag]

$NVCR appears we bottomed, and managed to gather a tremendous amount of shares during this bear raid! Again all contributions and gains go to Charity! I want the World to be a better place and want to live to see breakthroughs in the treatment of ALL cancer, we aren't there yet but I hope we are close! GLTA

[herbied47]

https://www.tipranks.com/news/the-fly/novocure-management-to-meet-with-piper-sandler …Plotting to get this share price higher. Pressure needs to be put to oust the CEO. That would send it flying! Tutes can’t be to happy about how the share price has been dismantled. Stay tuned!

[herbied47]

Piper Sandler analyst Jason Bednar upgraded Novocure to Overweight from Neutral with an unchanged price target of $45. The "overwhelming pressure" on the shares has pushed the stock to levels where the risk/reward is "simply too attractive to remain on the sidelines" ahead of the soon-to-be-released Phase 3 data in recurrent ovarian cancer, the analyst tells investors in a research note. The firm sees "reasons to be upbeat" on INNOVATE-3 data and likes the potential for shares to move higher from current levels.

[KIPK]

Is It WAY Oversold - OR - Was It WAY Overvalued??